drugset / Trial / NCT05389722
A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the drug levels of CC-92480 after coadministration with rifampin and itraconazole and the drug levels of digoxin and rosuvastatin after coadministration with CC-92480 in healthy participants.
Timeline
- Start
- 2022-06-09
- Primary completion
- 2022-11-12
- Completion
- 2022-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | — | — |
| Subject | Itraconazole | Small molecule | — | — |
| Subject | Mezigdomide | Small molecule | — | — |
| Subject | Rifampin | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
Indications
No indication recorded.